Opus Genetics, Inc. (IRD) stock forecast and price target
Price $3.98 · data as of November 13, 2026
12-month price target
Average target$13.94
Upside / downside+250.3%
Analysts17
ConsensusStrong buy
Low $8.00Average $13.94High $20.00
Gold marker: average target · white marker: today’s price ($3.98)
Analyst ratings
Strong buy 3Buy 14Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.29 | −61.9% | $13M |
| Next fiscal year ends December 31, 2027 | $-0.76 | +41.0% | $12M |
| Quarter after ends December 31, 2026 | $-0.09 | +57.1% | $1M |
Consensus of the analysts covering Opus Genetics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Opus Genetics stock price target?
The average 12-month target from 17 analysts is $13.94, 250.3% above the current price of $3.98 Targets range from $8.00 to $20.00.
Is Opus Genetics a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 14 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Opus Genetics expected to earn?
Analysts expect EPS of $-1.29 for the fiscal year ending December 31, 2026 and $-0.76 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.